Erratum: α-Cycloalkyl-substituted ω-keto-dicarboxylic acids as lipid regulating agents (Bioorganic and Medicinal Chemistry (2005) 13 (223) DOI: 10.1016/j.bmc.2004.09.046);α-Cycloalkyl-substituted ω-keto-dicarboxylic acids as lipid regulating agents

Bioorganic and Medicinal Chemistry

Volumn 13, Issue 1, 2005, Pages 223-236

  Bell, Roel P L ^a   Verdijk, Dennis ^a   Relou, Mike ^a   Smith, Dennis ^a   Regeling, Henk ^a   Ebbers, Eelco J ^a   C Leemhuis, Frank M ^a   Oniciu, Daniela C ^b   Cramer, Clay T ^b   Goetz, Brian ^b   Pape, Michael E ^b   Krause, Brian R ^b   Dasseux, Jean Louis ^b  

^a Mercachem BV   (Netherlands)

^b PFIZER INC   (United States)

Author keywords

Cycloalkyl; Dyslipidemia; HDL cholesterol; TosMic

Indexed keywords

1 [9 (1 CARBOXYCYCLOBUTYL) 5 OXONONYL] 1 CYCLOBUTANECARBOXYLIC ACID; 1 [9 [1 (ETHOXYCARBONYL)CYCLOBUTYL] 5 OXONONYL] 1 CYCLOBUTANECARBOXYLATE; 2,12 DIHYDROXY 2,12 DIMETHYL 7 TRIDECANONE; ACETIC ACID; CARBOXYLIC ACID DERIVATIVE; DICARBOXYLIC ACID DERIVATIVE; DIETHYL 10 OXO 2,2,18,18 TETRAMETHYL NONADECANEDIOATE; DIMETHYL 6,6 DIMETHOXYUNDECANEDIOATE; ETHYL 1 (4 CHLOROBUTYL) 1 CYCLOBUTANECARBOXYLATE; ETHYL 1 (4 CHLOROBUTYL) 1 CYCLOPENTANECARBOXYLATE; ETHYL 1 (4 IODOBUTYL) 1 CYCLOBUTANECARBOXYLATE; ETHYL 1 (5 CHLOROPENTYL) 1 CYCLOPENTANECARBOXYLATE; ETHYL 1 (5 IODOPENTYL) 1 CYCLOPENTANECARBOXYLATE; ETHYL 1 [11 [1 (ETHOXYCARBONYL)CYCLOPENTYL] 6 OXOUNDECYL] 1 CYCLOPENTANECARBOXYLATE; ETHYL 1 [9 [1 (ETHOXYCARBONYL)CYCLOPENTYL] 5 OXONONYL] 1 CYCLOPENTANECARBOXYLATE; ETHYL 11 [1 (ETHOXYCARBONYL)CYCLOBUTYL] 2,2 DIMETHYL 7 OXOUNDECANOATE; ETHYL 11 [1 (TERT BUTOXYCARBONYL)CYCLOPROPYL] 2,2 DIMETHYL 7 OXOUNDECANOATE; ETHYL 13 [1 (TERT BUTOXYCARBONYL)CYCLOPROPYL] 2,2 DIMETHYL 8 OXOTRIDECANOATE; ETHYL 2,2 DIMETHYL 8 OXO 10 PHENYLDECANOATE; ETHYL 2,2 DIMETHYL 9 BROMONONANOATE; TERT BUTYL 1 (4 CHLOROBUTYL) 1 CYCLOPROPANECARBOXYLATE; TERT BUTYL 1 (4 IODOBUTYL) 1 CYCLOPROPANECARBOXYLATE; TERT BUTYL 1 (5 CHLOROPENTYL) 1 CYCLOPROPANECARBOXYLATE; TERT BUTYL 1 (5 IODOPENTYL) 1 CYCLOPROPANECARBOXYLATE; TERT BUTYL 1 [11 [1 (TERT BUTOXYCARBONYL)CYCLOPROPYL] 6 OXOUNDECYL] 1 CYCLOPROPANECARBOXYLATE; TERT BUTYL 1 [9 [1 (TERT BUTOXYCARBONYL)CYCLOPROPYL] 5 OXONONYL] 1 CYCLOPROPANECARBOXYLATE; TETRAETHYL 7 OXO 2,2,12,12 TRIDECANETETRACARBOXYLATE; UNCLASSIFIED DRUG; UNINDEXED DRUG; [7 ETHOXY 6,6 DIMETHYL 1 [(4 METHYLPHENYL)SULFONYL] 7 OXOHEPTYL] (METHYLIDYNE)AMMONIUM; [8 ETHOXY 7,7 DIMETHYL 1 [(4 METHYLPHENYL)SULFONYL] 8 OXOOCTYL] (METHYLIDYNE)AMMONIUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG SYNTHESIS; FEMALE; IC 50; ISOTOPE LABELING; LIPID METABOLISM; LIPOGENESIS; LIVER CELL CULTURE; NONHUMAN; RAT; RAT STRAIN;

EID: 9644270345     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2004.12.021     Document Type: Erratum

References (26)

1. Dasseux, J.-L. H.; Oniciu, D. C. Ether Compounds. US 6,459,003, 2002; US Pat. Appl. 09/540,738 March 31, 2000
2. Dasseux, J.-L. H.; Oniciu, D. C. Methods for synthesizing Ether Compounds and Intermediates Therefor. US 6,410,802, 2002; US Pat. Appl. 09/540,740 March 31, 2000
3. R. Mueller, J. Yang, C. Duan, E. Pop, L.H. Zhang, T.-B. Huang, A. Denisenko, O.V. Denisko, D.C. Oniciu, C.L. Bisgaier, M.E. Pape, C.D. Freiman, B. Goetz, C.T. Cramer, K.L. Hopson, and J.-L.H. Dasseux Long hydrocarbon chain ether-diols and -diacids that favorably alter lipid disorders in vivo J. Med. Chem. 47 2004 ASAP article, web release September 10, 2004
4. R. Mueller, J.; Yang, C. Duan, E. Pop, O.J. Geoffroy, L.H. Zhang, T.-B. Huang, S. Denisenko, B.H. McCosar, D.C. Oniciu, C.L. Bisgaier, M.E. Pape, C.D. Freiman, B. Goetz, C.T. Cramer, K.L. Hopson, and J.-L.H. Dasseux Long hydrocarbon chain keto-diols and -diacids that favorably alter lipid disorders in vivo J. Med. Chem. 47 2004 5183 5197
5. F. Wroblewski, and J.S. La Due Lactic dehydrogenase activity in blood Proc. Soc. Exp. Biol. Med. 90 1955 210 213
6. H. Elokdah, T.S. Sulkowski, M. Abou-Gharbia, J.A. Butera, S.-Y. Chai, G.R. McFarlane, M.-L. McKean, J.L. Babiak, S.J. Adelman, and E.M. Quinet Design, synthesis, and biological evaluation of thio-containing compounds with HDL-cholesterol-elevating properties J. Med. Chem. 47 2004 681 695
7. C. Cramer, B. Goetz, K. Hopson, G. Fici, R. Ackermann, S. Brown, C. Bisgaier, W.G. Rajeswaran, D.C. Oniciu, and M.E. Pape Effects of a novel dual lipid synthesis inhibitor and its potential utility in treating dyslipidemia and metabolic syndrome J. Lipid Res. 45 2004 1289 1301
8. P.O. Seglen Hepatocyte suspensions and cultures as tools in experimental carcinogenesis J. Toxicol. Environ. Health 5 1979 551 560
9. K.A. Kieft, T.M. Bocan, and B.R. Krause Rapid on-line determination of cholesterol distribution among plasma lipoproteins after high-performance gel filtration chromatography J. Lipid Res. 32 1991 859 866
10. Dasseux, J.-L. H.; Oniciu, D. C. Ketone compounds and compositions for cholesterol management and related uses. US Pat. Appl. 20030078239, October 11 2001
11. O. Possel, and A.M. van Leusen Tetrahedron Lett. 17 1977 4229 4232
12. K. Kurosawa, M. Suenaga, T. Inazu, and T. Yoshino Tetrahedron Lett. 23 1982 5335 5338
13. J.S. Yadav, and V.R. Gadgil Tetrahedron Lett. 31 1990 6217 6218
14. D. van Leusen, and A.M. van Leusen Synthetic Uses of Tosylmethyl Isocyanide (TosMIC) L.E. Overman Organic Reactions Vol. 57 2001 John Wiley and Sons New York 417 666
15. H.W. Pinnick, Y.-H. Chang, S.C. Foster, and M. Govindan J. Org. Chem. 45 1980 4505 4507
16. R. Haener, T. Maetzke, and D. Seebach Helv. Chim. Acta 69 1986 1655 1665
17. See Experimental section
18. v.H. Pechmann, and N.V. Sidgwick Chem. Ber 37 1904 3816 3829
19. P. Klotz, A. Slaoui-Hasnaoui, J.-L. Banères, J.-F. Duckert, J.-C. Rossi, and A. Kerbal J. Med. Chem. 41 1998 2278 2288
20. This batch of 7i (90% pure by GC) was used in another reaction without further purification. Another batch of 7i (>95% pure), prepared via a different though irreproducible method, was used for the biological tests
21. K.W.F. Kohlrausch, and R. Skrabal Z. Elektrochem. Angew. Phys. Chem. 43 1937 282 285
22. B. Török, and Á. Molnár J. Chem. Soc., Perkin Trans. 1 7 1993 801 804
23. A.M. Youssef, M.K. Safo, R. Danquah-Danso, G.S. Joshi, J. Kister, M.C. Marden, and D.J. Abraham J. Med. Chem. 45 2002 1184 1195
24. N. Ackerley, A.G. Brewster, G.R. Brown, D.S. Clarke, A.J. Foubister, S.J. Griffin, J.A. Hudson, M.J. Smithers, and P.R.O. Whittamore J. Med. Chem. 38 1995 1608 1628
25. This batch of 5a (>95% pure by GC) was purified by distillation
26. P.C. Astles, M.J. Ashton, A.W. Bridge, N.V. Harris, T.W. Hart, D.W. Parrot, B. Porter, D. Ridell, C. Smith, and R.J. Williams J. Med. Chem. 39 1996 1423 1432